Project nGage for HIV
(nGage Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new approach to help people living with HIV stay in care and maintain low virus levels. The treatment, called Project nGage, involves support from a person in the participant's social network, such as a friend or family member, along with regular interactions with a case manager. The trial will compare this method to the usual HIV care. Ideal candidates are English-speaking adults aged 18-49 who have missed HIV care visits or have not recently controlled their virus, and who live in Chicagoland or Alabama. As an unphased trial, this study offers a unique opportunity to contribute to innovative HIV care strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Project nGage intervention is safe?
Research has shown that Project nGage was tested in earlier studies. These studies examined how social networks can help people with HIV adhere to their treatment plans. The program includes selecting a support person, conducting face-to-face meetings, and providing regular follow-ups through text or phone calls.
Results from these studies have been mostly positive, indicating that Project nGage can help people attend appointments and take medication as prescribed. However, challenges have arisen, such as ensuring full participation in the program.
Regarding safety, Project nGage is a behavioral program, meaning it doesn't involve new drugs or medical procedures. This generally suggests it is well-tolerated. No solid evidence of harmful effects exists, and since it relies on support and communication, it is considered safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about Project nGage because it introduces a new approach to supporting people with HIV through social networks. Unlike standard treatments that mainly focus on medical care, Project nGage emphasizes the role of a Support Confidant to help patients stick to their treatment plans. This method involves interactive sessions that are personalized and can be delivered via text or phone, making it more flexible and accessible. By enhancing social support, the intervention aims to improve adherence to treatment and overall health outcomes, which could be a game-changer in managing HIV.
What evidence suggests that the Project nGage intervention is effective for promoting retention in care and viral suppression among people living with HIV?
Research has shown that Project nGage, which participants in this trial may receive, might help people with HIV remain engaged in their healthcare. A previous study found that using social networks can reduce risky behaviors related to HIV and increase HIV counseling and testing. Project nGage involves a trusted person in the participant's life to provide support. This method has shown promise in keeping young Black men who have sex with men involved in HIV care. By leveraging existing social support, Project nGage aims to improve health outcomes, such as maintaining viral control.16789
Who Is on the Research Team?
Alida Bouris, PhD
Principal Investigator
University of Chicago
David S Batey, PhD
Principal Investigator
Tulane University
Are You a Good Fit for This Trial?
This trial is for young Black sexual minority men aged 18-35 with HIV who speak English, own a personal cell phone, and have missed an HIV care visit in the past year. They must identify as cisgender men and agree to involve a non-romantic social support person in the intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Project nGage intervention with selection and invitation of a Support Confidant (SC), a face-to-face session, and quarterly mini-booster sessions
Re-randomization and Continued Intervention
Participants re-randomized to continue receiving mini-boosters or return to treatment as usual
Follow-up
Participants are monitored for retention in care and viral suppression
What Are the Treatments Tested in This Trial?
Interventions
- Project nGage
Project nGage is already approved in United States for the following indications:
- Improving retention in care and viral suppression among young Black sexual minority men (YBSMM) aged 18-35
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Thrive Alabama
Collaborator
Howard Brown Health
Collaborator
1917 Clinic at the University of Alabama at Birmingham
Collaborator
Tulane University
Collaborator
University of Alabama at Birmingham
Collaborator
Birmingham AIDS Outreach
Collaborator
Chicago Center for HIV Elimination
Collaborator